Posts

Showing posts from February, 2021

Thyroid eye disease Market Analysis

  (Albany, US) DelveInsight has launched a new report on Thyroid eye disease Market Insights, Epidemiology, and Market Forecast-2030 . DelveInsight's "  Thyroid eye disease Market Insights, Epidemiology, and Market Forecast-2030"  report delivers an in-depth understanding of the Thyroid eye disease, historical and forecasted epidemiology as well as the Thyroid eye disease market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. Some of Thyroid eye disease Facts : ·          In a study by Zagaria et al. [2011], it was observed that approximately 25‐30% of patients with Graves’ disease have clinical evidence of Graves’ ophthalmopathy. ·          As per the study by Liaboe et al., titled “An Introductory Tutorial and Overview of Disease”, TED has a higher prevalence in women than men (16 per 100,000 vs. 3 per 100,000, respectively). Both men and women demonstrate a bimodal pattern of age of diagnosis(40–44 and 60–64 year

Lewy Body Dementia Market Analysis

 (Albany, US) DelveInsight's  Lewy Body Dementia Market Analysis Report proffers a comprehensive outlay of the Lewy Body Dementia Epidemiological analysis focusing on the incidence and diagnosed patient pool segmented on the basis of several factors, as well as the Lewy Body Dementia market analysis in the 7MM (the US, EU5 (the UK, France, Germany, Italy and Spain) and Japan). The report covers the Lewy Body Dementia market trends covering key pharmaceutical companies in the market, upcoming as well as Lewy Body Dementia marketed therapies, unmet needs, prevailing constraints and the factors driving the market size growth. Some of the key highlights from the Lewy Body Dementia Market Report : LBD is the third-most common cause of dementia, thereby accounting for 5% to 10% of total cases. Lewy body is also estimated to be found in other brain disorders such as Alzheimer’s disease and Parkinson’s disease. ·          Men had a higher incidence of DLB than

Scleroderma Market Size, Epidemiology, Leading Companies, Drugs And Competitive Analysis By DelveInsight

  (Albany, US) DelveInsight has launched a new report on Scleroderma Market Insights, Epidemiology, and Market Forecast-2030 . DelveInsight's "  Scleroderma Market Insights, Epidemiology, and Market Forecast-2030"  report delivers an in-depth understanding of the Scleroderma, historical and forecasted epidemiology as well as the Scleroderma market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. Some of Scleroderma facts : ·          In the United States, the prevalence of scleroderma is 240 per million and an annual incidence of 19 per million.  ·          In Europe, the prevalence of scleroderma is estimated to be between 10 and 150 per million people, while the annual incidence has been reported to be between 3 and 28 per million people.  ·          Women are four times more prone to develop systemic scleroderma than men. Request for Free Sample Report: https://www.delveinsight.com/sample-request/scleroderma-m

Neurofibromatosis Type 2 Market Size, Epidemiology, Leading Companies, Drugs and Competitive Analysis by DelveInsight

 (Albany, US) DelveInsight has launched a new report on "Neurofibromatosis 2 Market Insights, Epidemiology, and Market Forecast-2030". DelveInsight's "  Neurofibromatosis 2 Market Insights, Epidemiology, and Market Forecast-2030"   report delivers an in-depth understanding of the Neurofibromatosis 2 , historical and forecasted epidemiology as well as the Neurofibromatosis 2 market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. Some of Neurofibromatosis type 2 Facts: ·          As per National Organization for Rare Disorders, the estimated incidence of NF2 is 1 in 33,000 people worldwide. The average age of onset is 18 to 24 years. [2018] ·          As per the Orphanet, the prevalence of Neurofibromatosis type 2 (initially estimated at 1: 200,000) is around 1 in 60,000. [2018] ·          According to Children’s Tumor Foundation, most people develop symptoms in the late teen and early adult years, althoug

Heavy Metal Poisoning Market Size, Epidemiology, Leading Companies, Drugs and Competitive Analysis by DelveInsight

 (Albany, US) DelveInsight has launched a new report on "  Heavy Metal Poisoning Market Insights, Epidemiology, and Market Forecast-2030 " DelveInsight's "  Heavy Metal Poisoning Market Insights, Epidemiology, and Market Forecast-2030"  report delivers an in-depth understanding of the Heavy Metal Poisoning, historical and forecasted epidemiology as well as the Heavy Metal Poisoning market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. Some of Heavy Metal Poisoning Facts : ·          The 2013 Annual Report of the American Association of Poison Control Centers' National Poison Data System documented about 1300 single exposures to mercury or compounds containing mercury. Of these, 109 were in children younger than 6 years and 673 were in persons older than 19 years. ·          Between 1996 and 2017, there were 1313 deaths in the cohort (including 181 cardiovascular and 33 respiratory) reported in France.